French startup Bioptimus, which aims to create an AI foundation model for biology to drive research and innovation, announced its launch with $35 million in seed funding. Sofinnova Partners led the round with support from…Continue Reading
Inato, the leading technology platform enabling access to inclusive clinical trials, today announced the close of $20 million in Series A2 funding from existing and new investors. The fundraise includes return and lead investor…Continue Reading
Almost three-quarters of all clinical trials are run by the same 5% of academic sites, according to Inato CEO Kourosh Davarpanah.
“This lack of patient access causes trial delays and costs to skyrocket, ultimately constraining…
In todays fast-paced world, it is easy to miss out on important information, especially if you are trying to keep up with a lot of different sources. That is where the daily digest comes in – it is a tool that compiles all the posts created on the previous day, providing you with a convenient summary of everything that happened so you can stay informed, educated, and engaged with the Digital Health world around you.Continue Reading
What You Should Know:– Inato, a technology platform that connects pharma companies (trial sponsors) with community-based trial sites raises $20M in new funding (A2) led by Cathay Innovation with participation from existing investor Obvious…Continue Reading
Clinical trial startup Inato scooped up $20 million in a Series A2 funding round led by Cathay Innovation.The raise included returning investor Obvious Ventures and new participants La Maison and Top Harvest Capital. The…Continue Reading